MEDI-490: Filed IND to conduct Phase I trial

MedImmune Inc. (MEDI), Gaithersburg, Md. Product: MEDI-490 recombinant BCG vaccine containing outer surface protein A from Borrelia burgdorferi, the causative microbe in Lyme disease Indication: Lyme ...